Professional
Added to YB: 2025-06-09
Pitch date: 2025-03-31
BAX [neutral]
Baxter International Inc.
-43.12%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States.
Market Cap
$9.3B
Pitch Price
$33.67
Price Target
N/A
Dividend
0.22%
EV/EBITDA
7.79
P/E
-26.24
EV/Sales
1.57
Sector
Health Care Equipment and Supplies
Category
turnaround
Show full summary:
Macquarie Value Fund Portfolio Holding: Baxter International Inc.
BAX (holding update): Medical products maker completing transformation by selling/spinning off units to focus on core business. $3B from Vantive kidney care sale in Jan will reduce debt. Disrupted by Hurricane Helene at largest US facility. 4-5% revenue growth expected for FY2025.